Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

Published:2017-07 Issue:10089 Volume:390 Page:40-49
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Papp Kim,Thaçi Diamant,Marcoux Danielle,Weibel Lisa,Philipp Sandra,Ghislain Pierre-Dominique,Landells Ian,Hoeger Peter,Kotkin Carol,Unnebrink Kristina,Seyger Marieke,Williams David

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Psoriasis: report by the Secretariat,2013

2. Global epidemiology of psoriasis: a systematic review of incidence and prevalence;Parisi;J Invest Dermatol,2013

3. A comparative study of pediatric onset psoriasis with adult onset psoriasis;Raychaudhuri;Pediatr Dermatol,2000

4. Incidence of psoriasis in children: a population-based study;Tollefson;J Am Acad Dermatol,2010

5. Epidemiology and comorbidity of psoriasis in children;Augustin;Br J Dermatol,2010

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies;Medicine;2024-08-09

2. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis;Dermatologic Clinics;2024-07

3. How can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases?;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

4. Comment on: Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis;Rheumatology;2024-01-17

5. Epidemiology, comorbidity, and use of systemic therapies in patients with paediatric psoriasis in Germany;Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen;2023-12